Subject: FW: Partner Announcement
From: "Averhoff, Francisco (CDC/OID/NCHHSTP)" <[email-masked]>
To: Tinatin Kuchuloria; Lika; Skaggs, Beth (CDC/CGH/DGHP); 'Irinka Tskhomelidze'; Gamkrelidze, Amiran (CDC ncdc.ge); David Sergeenko; Betty Chiang; Gregg Alton
Cc: Nasrullah, Muazzam (CDC/OID/NCHHSTP); Glass, Nancy (CDC/OID/NCHHSTP)
Date: Mon, 5 Feb 2018 13:58:52 +0000

Dear all, in case you are not aware, best, FA

Francisco Averhoff MD, MPH

CAPT US Public Health Service

Associate Director for Global Health

Division of Viral Hepatitis

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

Centers for Disease Control and Prevention

1600 Clifton Road, MS G-37

Atlanta, GA 30333

phone: 404-718-8501

fax: 404-718-8588

e-mail:
[email-masked]

From: Efird, Jeff (CDC/OID/NCHHSTP)

Sent: Thursday, February 01, 2018 3:15 PM

To: Averhoff, Francisco (CDC/OID/NCHHSTP) <[email-masked]>

Subject: FW: Partner Announcement

Importance: High

Here is the announcement for partners.

Subject: Division of Viral Hepatitis Leadership Announcement

Dear colleagues:

Times of transition can be challenging, and it is with mixed emotions that I am announcing that Dr. John Ward has accepted an opportunity with the Task Force for Global Health where
he will assist the organization in developing global viral hepatitis prevention, treatment, and control programs. Dr. Ward will begin this assignment as a secondee from U.S. Centers for Disease Control and Prevention on March 5, 2018.

Dr. Ward made major contributions and accomplishments throughout his 13-year tenure as CDC’s Director of the Division of Viral Hepatitis, from raising the profile of viral hepatitis
nationally and internationally to developing groundbreaking guidelines on screening for hepatitis C; from documenting the association between the resurgence of new hepatitis C and B infections with the opioid crisis to supporting the development of the first
HHS National Viral Hepatitis Action Plan; from implementing cutting edge test and cure pilot programs to envisioning the National Academies of Sciences report that ultimately proposed goals for viral hepatitis elimination in the United States.

We will immediately announce a detail opportunity to identify someone to serve as the Acting Division Director while we conduct a national search for a permanent Director for the Division
of Viral Hepatitis.

Sincerely,

Jonathan Mermin, MD, MPH

RADM and Assistant Surgeon General, USPHS

Director, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

Centers for Disease Control and Prevention

Rachel L.C. Powell

Acting Associate Director for Communication Science

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

U.S. Centers for Disease Control and Prevention